Results 141 to 150 of about 12,082 (200)

Global and Regional Burden of Seborrheic Dermatitis: Trends in Incidence and DALYs, 1990-2021. [PDF]

Clin Cosmet Investig Dermatol
Hao Z, Zhao X, Chen J, Li B, Xu W, Zhang L.   +5 more
europepmc   +1 more source

Prevalence and Severity of Mental Health Symptoms With Seborrheic Dermatitis: A Systematic Review and Meta-Analysis. [PDF]

Int J Dermatol
Chen J, Li C, Chang CH, Polaskey MT, Chovatiya R.   +4 more
europepmc   +1 more source

The psychosocial dimensions of seborrheic dermatitis: A cross-sectional study on anxiety, personality, and quality of life. [PDF]

PLoS One
Taş Aygar G, Karataş H, Kaya E, Borazan NŞ, Kartal SP.   +4 more
europepmc   +1 more source

Metabolomics in Scalp Seborrheic Dermatitis Evidenced Key Changes in Inflammatory Markers Following a 10-Week Scalp Care Scheme with an Anti-dandruff Shampoo. [PDF]

Dermatol Ther (Heidelb)
Géniès C, Maître M, Baradat S, Froliger M, Turlier V, Mercadié A, Simcic-Mori A, Gravier E, Lauze C, Huyghe C, Alvarez-Georges S, Chansard N, Marinescu R, Reygagne P, Bessou-Touya S, Mengeaud V, Duplan H.   +16 more
europepmc   +1 more source

Seborrheic Dermatitis: Exploring the Complex Interplay with <i>Malassezia</i>. [PDF]

Int J Mol Sci
Piacentini F, Camera E, Di Nardo A, Dell'Anna ML.   +3 more
europepmc   +1 more source

Improvement in facial seborrheic dermatitis following cervical transcutaneous vagal nerve stimulation. [PDF]

JAAD Case Rep
Nahm WJ, Kim KJ, Namgung E, Falanga V, Chen R, Lee DA, Schmitt K, Koo J.   +7 more
europepmc   +1 more source

Child and Adult Seborrheic Dermatitis: A Narrative Review of the Current Treatment Landscape. [PDF]

Dermatol Ther (Heidelb)
Vidal SI, Menta N, Green L.
europepmc   +1 more source

Potential Applications of Chitosan in Seborrheic Dermatitis and Other Skin Diseases: A Comprehensive Review. [PDF]

Clin Cosmet Investig Dermatol
Liu Y, Shang J, Chen Y, Feng X.
europepmc   +1 more source

Long-Term Safety and Efficacy of Roflumilast Foam 0.3% in Patients with Seborrheic Dermatitis: A Phase II, Open-Label Trial of up to 52 Weeks. [PDF]

Am J Clin Dermatol
Alexis AF, Bukhalo M, Cook-Bolden FE, Del Rosso JQ, Draelos ZD, DuBois JC, Ferris LK, Forman SB, Kempers SE, Kircik LH, Lain E, Moore AY, Pariser DM, Raoof J, Zirwas MJ, Seal MS, Kato S, Chu DH, Krupa D, Snyder S, Burnett P, Berk DR.   +21 more
europepmc   +1 more source